On May 13, 2021 IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology company reported that IMV’s executive management team will be participating in two upcoming investor conferences (Press release, IMV, MAY 13, 2021, View Source [SID1234579885]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Sachs and Associates, 7th Annual Immuno-oncology Innovation Forum Panel

IMV panel participant: Fred Ors, President and CEO

Date: Wednesday, May 19, 2021

Time: 2:50 p.m. EDT

Registration: View Source

Only registered participants will be able to listen to this panel. Details to register can be found in the link above.

Family Office Investor Event – Healthcare & Biotech TSX Showcase

Date: Wednesday, May 19, 2021

Time: 10:00 a.m. EDT